Vimarsana
Biggest News Aggregation in the World

Pharma International News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma International. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma International Today - Breaking & Trending Today

NutraIngredients Awards 2024 Winners announced! - Vimarsana News

NutraIngredients Awards 2024 Winners announced!

NutraIngredients celebrated one decade of annual industry awards last night (May 15) with the winners of this year's competition announced at a VIP Party in Geneva.

2024 NutraIngredients Award finalists prioritizing women's health - Vimarsana News

2024 NutraIngredients Award finalists prioritizing women's health

The 2024 NutraIngredients Innovations in Women's Health Award finalists are innovating with solutions to target the symptoms of menopausal and human papillomavirus (HPV).

Investors in Hyphens Pharma International (Catalist:1J5) have seen favorable returns of 75% over the past five years - Vimarsana News

Investors in Hyphens Pharma International (Catalist:1J5) have seen favorable returns of 75% over the past five years

Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make...

Source: yahoo.com
Powerful Bulgarian Businessmen Buy 'Bad Apple' Bank in Moldova Mind the horns! - Vimarsana News

Powerful Bulgarian Businessmen Buy 'Bad Apple' Bank in Moldova Mind the horns!

The owner of Sopharma Pharmaceuticals Ognian Donev and the owner of Darik Radio (revealed to have been a collaborator of the Communist regime secret services with the alias “Karak") Radosvet Radev are on their way to become top bankers in the Republic of Moldova. Their joint venture DOVERIE UNITED-HOLDING PLC is purchasing a 63.9% stake…

Source: bivol.bg
Novartis announces strategic review of its India business - Vimarsana News

Novartis announces strategic review of its India business

Swiss pharma multinational Novartis AG has started a strategic review of its Indian arm, possibly with the intent of selling it off.